End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 PLN | 0.00% | +4.80% | -9.66% |
05-14 | Read-Gene S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-12 | Read-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Number of employees: 21
Sales per Business
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Research and Testing
99.6
%
| 7 | 99.6 % | 10 | 99.6 % | +40.11% |
Goods and Materials
0.4
%
| 0 | 0.4 % | 0 | 0.4 % | +47.84% |
Sales per region
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Poland
100.0
%
| 7 | 100.0 % | 10 | 100.0 % | +40.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Lubinski
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - | |
Karolina Kleszcz
ADM | Chief Administrative Officer | - | - |
Róza Derkacz
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Tomasz Huzarski
CHM | Chairman | - | - |
Jacek Gronwald
BRD | Director/Board Member | - | - |
Janusz Piróg
BRD | Director/Board Member | - | - |
Adam Szuba
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,449,731 | 2,340,279 ( 24.77 %) | 0 | 24.77 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-9.66% | 15.69M | |
-38.92% | 8.34B | |
+1.92% | 3.37B | |
-10.21% | 2.04B | |
-29.79% | 1.77B | |
-21.12% | 1.66B | |
+12.21% | 976M | |
+29.92% | 814M | |
-7.42% | 707M | |
-26.33% | 532M |
- Stock Market
- Equities
- RDG Stock
- Company Read-Gene S.A.